Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers

mBio

Volumn 5, Issue 6, 2014, Pages

  Oshansky, Christine M ^a   Wong, Sook San ^a   Jeevan, Trushar ^a   Smallwood, Heather S ^a   Webby, Richard J ^a   Shafir, Shira C ^b   Thomas, Paul G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H12N5; INFLUENZA VIRUS A H3N8; INFLUENZA VIRUS A H4N6; INFLUENZA VIRUS A H5N5; INFLUENZA VIRUS A H6N1; INFLUENZA VIRUS A H7N3; INFLUENZA VIRUS A H7N9; INFLUENZA VIRUS A H8N4; INTERFERON PRODUCTION; MALE; MIDDLE AGED; MIGRANT BIRD; NONHUMAN; OCCUPATIONAL EXPOSURE; PERIPHERAL BLOOD MONONUCLEAR CELL; POULTRY; SEROPREVALENCE; YOUNG ADULT; ZOONOSIS; ANIMAL; BIRD; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; NORTH AMERICA; SECRETION (PROCESS); T LYMPHOCYTE;

AVES; AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

ANIMALS; ANTIBODIES, VIRAL; BIRDS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; NORTH AMERICA; OCCUPATIONAL EXPOSURE; SEROEPIDEMIOLOGIC STUDIES; T-LYMPHOCYTES;

EID: 84920911854     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02107-14     Document Type: Article

References (48)

1. Palese P. 2004. Influenza: old and new threats. Nat. Med. 10:S82-S87. http://dx.doi.org/10.1038/nm1141.
2. Kilbourne ED. 2006. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12:9-14. http://dx.doi.org/10.3201/eid1201.051254.
3. Sorrell EM, Schrauwen EJ, Linster M, De Graaf M, Herfst S, Fouchier RA. 2011. Predicting “airborne” influenza viruses: (trans-) mission impossible? Curr. Opin. Virol. 1:635-642. http://dx.doi.org/10.1016/j.coviro.2011.07.003.
4. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO. 2012. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. U. S. A. 109:4269-4274. http://dx.doi.org/10.1073/pnas.1116200109.
5. Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, Chen LM, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Gilbert AT, Chang J, Guo Z, Davis CT, Paulson JC, Stevens J, Rupprecht CE, Holmes EC, Wilson IA, Donis RO. 2013. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9:e1003657. http://dx.doi.org/10.1371/journal.ppat.1003657.
6. Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 105: 17736-17741. http://dx.doi.org/10.1073/pnas.0807142105.
7. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF. 1999. Human infection with influenza H9N2. Lancet 354: 916-917. http://dx.doi.org/10.1016/S0140-6736(99)03311-5.
8. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
9. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha doQ, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. http://dx.doi.org/10.1038/nm1477.
10. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361. http://dx.doi.org/10.1073/pnas.0308352100.
11. Myers KP, Setterquist SF, Capuano AW, Gray GC. 2007. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin. Infect. Dis. 45:4-9. http://dx.doi.org/10.1086/518579.
12. Shafir SC, Fuller T, Smith TB, Rimoin AW. 2012. A national study of individuals who handle migratory birds for evidence of avian and swineorigin influenza virus infections. J. Clin. Virol. 54:364-367. http://dx.doi.org/10.1016/j.jcv.2012.05.001.
13. Puzelli S, Di Trani L, Fabiani C, Campitelli L, De Marco MA, Capua I, Aguilera JF, Zambon M, Donatelli I. 2005. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J. Infect. Dis. 192:1318-1322. http://dx.doi.org/10.1086/444390.
14. Lee LY, Ha doLA, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 118:3478-3490.
15. Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y, Skehel JJ. 2004. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325:287-296. http://dx.doi.org/10.1016/j.virol.2004.04.040.
16. Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K. 1991. Comparison of complete amino acid sequences and receptorbinding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182:475-485. http://dx.doi.org/10.1016/0042-6822(91)90588-3.
17. Air GM. 1981. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 78: 7639-7643. http://dx.doi.org/10.1073/pnas.78.12.7639.
18. Medina RA, García-Sastre A. 2011. Influenza A viruses: new research developments. Nat. Rev. Microbiol. 9:590-603. http://dx.doi.org/10.1038/nrmicro2613.
19. Couch RB. 1975. Assessment of immunity to influenza using artificial challenge of normal volunteers with influenza virus. Dev. Biol. Stand. 28:295-306.
20. Clements ML, Betts RF, Tierney EL, Murphy BR. 1986. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24:157-160.
21. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, van Lier RA. 2005. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J. Exp. Med. 202:1433-1442. http://dx.doi.org/10.1084/jem.20051365.
22. Piet B, de Bree GJ, Smids-Dierdorp BS, van der Loos CM, Remmerswaal EB, von der Thüsen JH, van Haarst JM, Eerenberg JP, ten Brinke A, van der Bij W, Timens W, van Lier RA, Jonkers RE. 2011. CD8(+) T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Invest. 121:2254-2263. http://dx.doi.org/10.1172/JCI44675.
23. Hillaire ML, van Trierum SE, Bodewes R, van Baalen CA, van Binnendijk RS, Koopmans MP, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2011. Characterization of the human CD8(+) T cell response following infection with 2009 pandemic influenza H1N1 virus. J. Virol. 85:12057-12061. http://dx.doi.org/10.1128/JVI.05204-11.
24. Khurelbaatar N, Krueger WS, Heil GL, Darmaa B, Ulziimaa D, Tserennorov D, Baterdene A, Anderson BD, Gray GC. 2013. Sparse evidence for equine or avian influenza virus infections among Mongolian adults with animal exposures. Influenza Other Respir. Viruses 7:1246-1250. http://dx.doi.org/10.1111/irv.12148.
25. Coman A, Maftei DN, Krueger WS, Heil GL, Friary JA, Chereches RM, Sirlincan E, Bria P, Dragnea C, Kasler I, Gray GC. 2013. Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers. J Infect. Public Health 6:438-447. http://dx.doi.org/10.1016/j.jiph.2013.05.003.
26. Bridges CB, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu X, Cox NJ, Katz JM. 2002. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J. Infect. Dis. 185:1005-1010. http://dx.doi.org/10.1086/340044.
27. Gill JS, Webby R, Gilchrist MJ, Gray GC. 2006. Avian influenza among waterfowl hunters and wildlife professionals. Emerg. Infect. Dis. 12: 1284-1286. http://dx.doi.org/10.3201/eid1708.060492.
28. Gray GC, McCarthy T, Capuano AW, Setterquist SF, Alavanja MC, Lynch CF. 2008. Evidence for avian influenza A infections among Iowa’s agricultural workers. Influenza Other Respir. Viruses 2:61-69. http://dx.doi.org/10.1111/j.1750-2659.2008.00041.x.
29. Khuntirat BP, Yoon IK, Blair PJ, Krueger WS, Chittaganpitch M, Putnam SD, Supawat K, Gibbons RV, Pattamadilok S, Sawanpanyalert P, Heil GL, Friary JA, Capuano AW, Gray GC. 2011. Evidence for subclinical avian influenza virus infections among rural Thai villagers. Clin. Infect. Dis. 53:e107-e116. http://dx.doi.org/10.1093/cid/cir525.
30. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, Ophorst C, Cox F, Korse HJ, Brandenburg B, Vogels R, Brakenhoff JP, Kompier R, Koldijk MH, Cornelissen LA, Poon LL, Peiris M, Koudstaal W, Wilson IA, Goudsmit J. 2011. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850. http://dx.doi.org/10.1126/science.1204839.
31. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856. http://dx.doi.org/10.1126/science.1205669.
32. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao HX, Harrison SC. 2011. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. U. S. A. 108:14216-14221. http://dx.doi.org/10.1073/pnas.1111497108.
33. Pica N, Palese P. 2013. Toward a universal influenza virus vaccine: prospects and challenges. Annu. Rev. Med. 64:189-202. http://dx.doi.org/10.1146/annurev-med-120611-145115.
34. Corti D, Suguitan AL, Jr, Pinna D, Silacci C, Fernandez-Rodriguez BM, Vanzetta F, Santos C, Luke CJ, Torres-Velez FJ, Temperton NJ, Weiss RA, Sallusto F, Subbarao K, Lanzavecchia A. 2010. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120:1663-1673. http://dx.doi.org/10.1172/JCI41902.
35. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O’Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193. http://dx.doi.org/10.1084/jem.20101352.
36. Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, Chang CY, Davis CW, McCausland M, Elbein R, Edupuganti S, Spearman P, Andrews SF, Wilson PC, García-Sastre A, Mulligan MJ, Mehta AK, Palese P, Ahmed R. 2014. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl. Acad. Sci. U. S. A. 111:13133-13138. http://dx.doi.org/10.1073/pnas.1414070111.
37. Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P. 2013. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci. Transl. Med. 5:198ra107. http://dx.doi.org/10.1126/scitranslmed.3006637.
38. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P. 2013. Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J. Virol. 87: 8235-8240. http://dx.doi.org/10.1128/JVI.01085-13.
39. Medina RA, Stertz S, Manicassamy B, Zimmermann P, Sun X, Albrecht RA, Uusi-Kerttula H, Zagordi O, Belshe RB, Frey SE, Tumpey TM, García-Sastre A. 2013. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci. Transl. Med. 5:187ra170. http://dx.doi.org/10.1126/scitranslmed.3005996.
40. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, Mulligan M, Das SR, Yewdell JW, Mehta AK, Wilson PC, Ahmed R. 2012. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly crossreactive memory B cells. Proc. Natl. Acad. Sci. U. S. A. 109:9047-9052. http://dx.doi.org/10.1073/pnas.1118979109.
41. Mozdzanowska K, Furchner M, Washko G, Mozdzanowski J, Gerhard W. 1997. A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J. Virol. 71:4347-4355.
42. Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W. 2006. Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology 352:418-426. http://dx.doi.org/10.1016/j.virol.2006.05.008.
43. Feng JQ, Mozdzanowska K, Gerhard W. 2002. Complement component C1q enhances the biological activity of influenza virus hemagglutininspecific antibodies depending on their fine antigen specificity and heavychain isotype. J. Virol. 76:1369-1378. http://dx.doi.org/10.1128/JVI.76.3.1369-1378.2002.
44. Keating R, Hertz T, Wehenkel M, Harris TL, Edwards BA, McClaren JL, Brown SA, Surman S, Wilson ZS, Bradley P, Hurwitz J, Chi H, Doherty PC, Thomas PG, McGargill MA. 2013. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat. Immunol. 14:1266-1276. http://dx.doi.org/10.1038/ni.2741.
45. Yayh B. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. Methodol. 57:289-300.
46. Core, R. Team. 2013. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
47. Revelle W. 2014. Psych: procedures for personality and psychological research, 1.4.8. Northwestern University, Evanston, IL. http://CRAN.R-project.org/package_psych.
48. Wei T. 2013. corrplot: visualization of a correlation matrix. R package version 0.73. http://CRAN.R-project.org/package_corrplot.